Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Information to shareholders: statutory migration

13 Oct 2025 15:30

RNS Number : 1582D
B&M European Value Retail S.A.
13 October 2025
 

B&M European Value Retail S.A.

3, rue Gabriel Lippmann, L-5365 Munsbach,

Luxembourg.

 

13 October 2025

 

Information to shareholders in relation to Shareholding and Settlement Arrangements post Migration

B&M European Value Retail S.A. ("B&M Luxembourg" or the "Company") is pleased to provide further information to shareholders regarding the statutory Migration pursuant to which it will become, in law, B&M European Value Retail plc ("B&M Jersey"), a public limited company governed by the laws of Jersey and will cease to be a société anonyme ("S.A.") incorporated under the Laws of Luxembourg. 

Position regarding shareholdings prior to and following the Migration

Currently, the majority of the shareholders hold their shares either in the form of CREST Depository Interests ("CDIs") or indirectly through a broker, nominee or other custodian account with Euroclear. It is expected that the vast majority of the Company's existing shareholders will not need to take any action as a consequence of the Migration and that they will be able to continue to hold their interest in the Company's shares and to receive dividends in the same way as they do at the moment.

Dividend Mandates

Existing dividend mandates in respect of B&M Luxembourg shares will continue to be effective in relation to shares in B&M Jersey for all existing shareholders provided that any shareholders holding through CREST have enabled their CREST memorandum account to accept dividend payments via the CREST system in relation to their holdings.

Where can you find further information?

The Company has prepared an FAQ document for shareholders, which is available on the Company's website. Shareholders are advised to read the FAQ Document carefully to ensure that they understand the arrangements that will apply to them following the Migration being completed and the actions, if any, that they may wish to take.

Further updates on the Migration process

In anticipation of the Migration, an application will be made for admission of the B&M Jersey shares to the equity shares (commercial companies) category of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange ("LSE") in place of the B&M Luxembourg shares, upon completion of the Migration (together, the "Admission"). Subject to certain regulatory approvals, it is expected that Admission and unconditional dealings in B&M Jersey shares will become effective after the publication of B&M Luxembourg's interim results on 13 November 2025 and prior to the end of this calendar year.

A new International Securities Identification Number ("ISIN"), JE00BVSYJW51, has been issued in respect of the B&M Jersey shares and will become effective upon the Migration being completed and Admission becoming effective.

A prospectus relating to the Admission is expected to be published by the Company shortly before Admission becomes effective. An announcement will be made at the relevant time via the LSE Regulatory News Service ("RNS") notifying shareholders that the prospectus has been published and that a copy of it is available for inspection on the Company's website.

Disclaimer and Important Information

The information set out in this announcement is for informational purposes only and is not, and is not to be construed as being, legal, business, financial or tax advice. If you are in any doubt the contents of this announcement or the action you should take or any potential tax consequences relating to any changes in the way in which you hold your Shares, you should consult your own appropriately authorised legal adviser, financial adviser or tax adviser.

If you hold your shares through a nominee, broker, custodian, trustee or in an ISA then you should also consult the relevant nominee, broker, custodian, trustee or ISA provider for assistance.

Enquiries

 

B&M European Value Retail S.A.

For further information please contact: +44 (0) 151 728 5400

Alexander Simpson

Group General Counsel

 

Andrew Orchard

Head of Investor Relations 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOASRVOURAAA
Date   Source Headline
18th Jun 202610:00 amRNSBoard Retirement
18th Jun 202610:00 amRNSPublication of Annual Report and Notice of AGM
16th Jun 202612:00 pmRNSDirector/PDMR Shareholding
11th Jun 20261:00 pmRNSTiming of Q1 FY27 Trading Statement
3rd Jun 20267:00 amRNSFY26 Preliminary Results
10th Apr 20269:00 amRNSDirectorate Changes and Leadership Appointments
26th Mar 20264:45 pmRNSMajor Holding(s) in Company - TR1
24th Mar 20264:30 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:31 pmRNSMajor Holding(s) in Company - TR1
17th Mar 20265:30 pmRNSMajor Holding(s) in Company - TR1
9th Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:00 amRNSAdmission of B&M Jersey Shares
2nd Mar 20268:00 amRNSReadmission - B&M European Value Retail S.A.
27th Feb 20264:48 pmRNSMigration Completion
25th Feb 202611:00 amRNSPublication of a Prospectus - Migration
24th Feb 20261:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:00 pmRNSUpdate statement on 2025 AGM voting results
22nd Jan 20267:00 amRNSQ3 FY26 Trading Statement
15th Jan 20269:00 amRNSBlock listing Interim Review
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
23rd Dec 20252:00 pmRNSTiming of Q3 FY26 Trading Statement
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
19th Dec 20259:00 amRNSMajor Holding in Company - TR1
4th Dec 202510:00 amRNSMajor Holding in Company - TR1
28th Nov 202511:00 amRNSMajor Holding in Company - TR1
26th Nov 20259:30 amRNSMajor Holding in Company TR1
24th Nov 20252:30 pmRNSMajor Holding in Company- TR1
20th Nov 20254:00 pmRNSCEO Purchase of shares
20th Nov 202511:00 amRNSCEO Purchase of Shares
19th Nov 20259:01 amRNSCEO Purchase of Shares
19th Nov 20259:00 amRNSMajor Holding in Company TR1
18th Nov 202511:00 amRNSCEO Purchase of Shares
18th Nov 202510:58 amRNSMajor Holding in Company- TR1
14th Nov 20253:30 pmRNSMajor Holding in Company TR1
13th Nov 20257:00 amRNSFY26 Interim Results
4th Nov 20256:05 pmRNSMajor Holding in Company TR1
4th Nov 20256:00 pmRNSMajor Holding in Company TR1
30th Oct 20259:00 amRNSMajor Holding in Company TR1
28th Oct 20254:00 pmRNSMajor Holding in Company TR1
27th Oct 20251:01 pmRNSMajor Holding in Company TR1
27th Oct 20251:00 pmRNSMajor Holding in Company TR1
20th Oct 20257:00 amRNSUpdate on FY26 Guidance and Directorate Change
13th Oct 20253:30 pmRNSInformation to shareholders: statutory migration
7th Oct 20257:00 amRNSFY26 H1 Trading and Operational Update
22nd Sep 202511:30 amRNSCEO Purchase of Shares
18th Sep 20256:00 pmRNSDirector/PDMR Shareholding
15th Sep 20254:34 pmRNSCEO Purchase of Shares
11th Sep 202511:00 amRNSCEO Purchase of Shares
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20254:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.